Zhdanov VM. Live influenza vaccines in USSR: Development of studies and practical application. In: Kendal AP, Patriarca P (eds), Options for the control of influenza. New York: Alan R. Liss, 1986; 193–205.
Kendal AP, Maassab HF, Alexandrova GI, Ghendon YZ. Development of cold-adapted recombinant live, attenuated influenza A vaccines in the USA and USSR. Antiviral Research 1981; 1: 339–365.
Ghendon YZ, Polezhaev KV, Lisovskaya TE, et al. Recombinant cold-adapted attenuated influenza A vaccines for use in children: Molecular genetic analysis of the cold-adapted donor and recombinants. Infect Immun 1984; 44: 730–733.
Alexandrova GI, Maassab HF, Kendal AP, et al. Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates. Vaccine 1990; 8: 61–64.
Nevedomskaya GN, Medvedeva TE, Zhikhareva AI, et al. Evaluation of the degree of attenuation of cold-adapted influenza A virus strains in CBA mice and Syrian hamsters. Voprosi Virologii 1992; 37: 37–40 (in Russian).
Klimov AE, Cox NJ, Yotov WV, et al. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology 1992; 186: 795–797.
Alexandrova GI, Polezhaev FI, Budilovsky GN, et al. Recombinant cold-adapted attenuated influenza A vaccines for use in children: Reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from vaccinees. Infect Immun 1984; 44: 734–739.
Alexandrova GI, Budilovsky GN, Koval TA, et al. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: An epidemiological field trial. Vaccine 1986; 4: 114–118.
Slepushkin AN, Patriarca PA, Obrosova-Serova NP, et al. Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain. Vaccine 1988; 6: 25–28.
Slepushkin AN, Obrosova-Serova NP, Burtseva EI, et al. Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia, 1: Safety and efficacy in two Moscow schools, 1987/88. Vaccine 1993; 11: 323–328.
Rudenko LG, Lonskaya NI, Klimov AI, et al. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3–14 year olds. Bull WHO 1996; 74: 77–84.
Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Inf Dis 1993; 168: 881–887.
Obrosova-Serova NP, Slepushkin AN, Kendal AP, et al. Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses. Vaccine 1990; 8: 57–60.
Khan AS, Polezhaev F., Vasilijeva R, et al. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. J Inf Dis 1996; 173: 453–456.
Rudenko LG, Arden N, Grigorieva E, et al. Safety and immunogenicity of Russian live attenuated and US inactivated trivalent vaccines in the elderly. In: Brown LE, Hampson AW, Webster RG (eds), Options for the Control of Influenza III. Amsterdam: Elsevier, 1996; 572–578.
Klimov AE and Cox NJ. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. Journal of Virological Methods 1995; 52: 41–49.
Klimov AE, Egorov AY, Gushchina MI, et al. Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza viruses: Sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol 1995; 76: 1521–1525.
Klimov AI, Rudenko LG, Egorov AY, et al. Genetic stability of Russian cold-adapted live attenuated reassortant influenza vaccines. In: Brown LE, Hampson AW, Webster RG (eds), Options for the Control of Influenza III. Amsterdam: Elsevier, 1996; 129–136.